UCB Group (UCB): Company Profile and SWOT Analysis

Date: July 21, 2012
Pages: 37
Price:
US$ 125.00
License [?]:
Publisher: World Market Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: UE181EA1B08EN
Leaflet:

Download PDF Leaflet

UCB Group (UCB): Company Profile and SWOT Analysis
SYNOPSIS

World Market Intelligence's 'UCB Group (UCB): Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, competitive benchmarking, key facts, key employees, location and subsidiaries as well as information on products and services.

SUMMARY

This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.

WMI's 'UCB Group (UCB): Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.

WMI strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

SCOPE
  • Examines and identifies key information and issues about 'UCB Group' for business intelligence requirements
  • Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
  • Provides analysis on financial ratios along with a competitor benchmarking section
  • The profile also contains information on business operations, company history, major products and services, key employees
REASONS TO BUY
  • Quickly enhance your understanding of the company
  • Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
  • Recognize potential partnerships and suppliers
  • Obtain yearly profitability figures
KEY HIGHLIGHTS

UCB S.A. (UCB) is a biopharmaceutical company focused on the discovery and development of innovative medicines and solutions against various serious diseases. The company's development efforts are mainly focused on the central nervous system and immunology therapeutic domains. The core products of the company include Vimpat (lacosamide), Keppra (levetiracetam), Neupro (rotigotine), Nootropil (piracetam), Metadate CD (methylphenidate HCI), Cimzia (certolizumab pegol), Xyzal (levocetirizine), Zyrtec (cetirizine, including Zyrtec-D/Cirrus), and Tussionex (hydrocodone polistirex and chlorpheniramine polistirex). UCB markets its products through an internal sales force and through strategic alliances with other pharmaceutical companies. The company, along with its subsidiaries, operates in over 40 countries. It also maintains 10 research and development (R&D) centers in Europe, the US and Japan. UCB is headquartered in Brussels, Belgium.
1 BUSINESS ANALYSIS

1.1 Company Overview
1.2 Business Description
1.3 Major Products and Services

2 ANALYSIS OF KEY PERFORMANCE INDICATORS

2.1 Five Year Snapshot: Overview of Financial and Operational Performance Indicators
2.2 Key Financial Performance Indicators
  2.2.1 Revenue and Operating Profit
  2.2.2 Asset and Liabilities
  2.2.3 Net Debt vs. Gearing Ratio
  2.2.4 Solvency
  2.2.5 Valuation
2.3 Competitive Benchmarking
  2.3.1 Market Capitalization
  2.3.2 Efficiency
  2.3.3 Valuation
  2.3.4 Turnover – Inventory and Asset
  2.3.5 Liquidity

3 MERGERS & ACQUISITIONS AND PARTNERSHIPS

3.1 M&A and Partnerships Strategy

4 SWOT ANALYSIS

4.1 SWOT Analysis - Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats

5 COMPANY STATEMENT

6 HISTORY

7 KEY EMPLOYEE BIOGRAPHIES

8 LOCATIONS AND SUBSIDIARIES

8.1 Head Office
8.2 Other Locations and Subsidiaries

9 APPENDIX

9.1 Methodology
9.2 Ratio Definitions
9.3 Disclaimer

LIST OF TABLES

Table 1: Major Products and Services
Table 2: Key Ratios - Annual
Table 3: Key Ratios - Interim
Table 4: Key Capital Market Indicators
Table 5: History
Table 6: Key Employee Biographies
Table 7: Subsidiaries

LIST OF FIGURES

Figure 1: Revenue and Operating Profit
Figure 2: Financial Position
Figure 3: Solvency
Figure 4: Valuation
Figure 5: Market Capitalization
Figure 6: Efficiency
Figure 7: Valuation
Figure 8: Turnover – Inventory and Asset
Figure 9: Liquidity

COMPANIES MENTIONED

UCB Group
Skip to top


Rabobank Group: Company Profile and SWOT Analysis US$ 125.00 Mar, 2016 · 24 pages
Unum Group (UNM): Company Profile and SWOT Analysis US$ 125.00 May, 2016 · 41 pages
CUNA Mutual Group: SWOT Analysis & Company Profile US$ 120.00 Mar, 2012 · 16 pages

Ask Your Question

UCB Group (UCB): Company Profile and SWOT Analysis
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: